Invesco’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-67,986
| Closed | -$1.22M | – | 3834 |
|
|
2017
Q4 | $1.22M | Buy |
67,986
+4,126
| +6% | +$50.8K | ﹤0.01% | 2907 |
|
|
2017
Q3 | $754K | Sell |
63,860
-655
| -1% | -$7.35K | ﹤0.01% | 3152 |
|
|
2017
Q2 | $677K | Sell |
64,515
-13,799
| -18% | -$141K | ﹤0.01% | 3219 |
|
|
2017
Q1 | $861K | Sell |
78,314
-465,916
| -86% | -$5.41M | ﹤0.01% | 3117 |
|
|
2016
Q4 | $7.37M | Buy |
544,230
+425,437
| +358% | +$5.94M | ﹤0.01% | 1742 |
|
|
2016
Q3 | $1.46M | Buy |
118,793
+640
| +0.5% | +$7.54K | ﹤0.01% | 2748 |
|
|
2016
Q2 | $1.3M | Sell |
118,153
-738,946
| -86% | -$8.27M | ﹤0.01% | 2749 |
|
|
2016
Q1 | $9.37M | Sell |
857,099
-273,219
| -24% | -$3.45M | ﹤0.01% | 1463 |
|
|
2015
Q4 | $19.5M | Buy |
1,130,318
+168,152
| +17% | +$3.01M | 0.01% | 1162 |
|
|
2015
Q3 | $19.1M | Sell |
962,166
-163,696
| -15% | -$3.75M | 0.01% | 1163 |
|
|
2015
Q2 | $18.5M | Buy |
1,125,862
+1,008,924
| +863% | +$17.5M | 0.01% | 1250 |
|
|
2015
Q1 | $1.82M | Buy |
116,938
+9,024
| +8% | +$140K | ﹤0.01% | 2661 |
|
|
2014
Q4 | $1.54M | Buy |
107,914
+79,614
| +281% | +$841K | ﹤0.01% | 2680 |
|
|
2014
Q3 | $184K | Sell |
28,300
-1,200
| -4% | -$7.97K | ﹤0.01% | 3700 |
|
|
2014
Q2 | $203K | Hold |
29,500
| – | – | ﹤0.01% | 3694 |
|
|
2014
Q1 | $211K | Sell |
29,500
-7,200
| -20% | -$61.6K | ﹤0.01% | 3715 |
|
|
2013
Q4 | $345K | Sell |
36,700
-7,308
| -17% | -$52.1K | ﹤0.01% | 3623 |
|
|
2013
Q3 | $275K | Sell |
44,008
-300
| -0.7% | -$1.87K | ﹤0.01% | 3650 |
|
|
2013
Q2 | $291K | Buy |
+44,308
| New | +$352K | ﹤0.01% | 3530 |
|
Other funds holding SCMP
Invesco's SCMP Position: Q1 2018 in Review
Invesco sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 67,986 shares — an estimated $1.22M sold.
Invesco first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $19.5M in Q4 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Invesco reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Invesco sold 67,986 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.22M.
- Invesco first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Invesco's Sucampo Pharmaceuticals, Inc. position peaked at $19.5M in Q4 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Invesco's 13F filing for Q1 2018, filed 15 May 2018.